EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Standardized Kit-Based Sample Preparation for Multi-Attribute Method Analysis of Biotherapeutics

Tyler Scherzi, Alia Sagatova, Sandra Wilson, John P. Wilson

Pharmaceuticals · 04.11.2026 · 19 (11) · 1750

DOI: 10.3390/ph19111750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 04.11.2026. Verfasst von Tyler Scherzi und 3 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: LC–MS/MS-based Multi-Attribute Method (MAM) workflows are increasingly used to characterize biotherapeutic proteins using peptide mapping and site-specific monitoring of critical quality attributes (CQAs). Sample preparation can impact foulant carryover, digestion efficiency, host cell protein (HCP) detection, and can induce artifactual chemical modifications. Herein, we compared a published National Institute for Bioprocessing Research and Training (NIBRT) MAM workflow with the S-Trap™ MAM Kit using NISTmAb RM 8671 with and without foulants.

Methods

Both bottom-up workflows used tryptic digestion, performed in solution for NIBRT and on-trap for the S-Trap™ MAM Kit. Matched samples were prepared with or without added foulants from a panel of 42 bioprocess-relevant contaminants including salts, buffers, surfactants, stabilizers, and excipients. LC–MS/MS analysis compared peptide-mapping performance, foulant carryover, sequence coverage, HCP detection and background signals, as well as preparation-induced modifications, in particular deamidation. Protein recovery and complementary Tryp-N™ digestion were also evaluated.

Results

Compared with the NIBRT workflow, the S-Trap™ MAM Kit had higher NISTmAb protein recovery (92.3% versus 48.4%); both workflows yielded full sequence coverage given matched peptide input. The S-Trap™ workflow produced greater total LC–MS signal from non-product proteins like HCPs. Under the conditions evaluated, signals corresponding to polysorbate-80, Brij-35, PEG-8000 and other contaminants were not detected following S-Trap™ preparation. Lower measured deamidation at the evaluated NISTmAb sites was observed using the kit and Tryp-N™ provided complementary peptide-mapping coverage.

Conclusions

The S-Trap™ MAM Kit offers several advantages for NISTmAb sample preparation: higher recovery, greater LC-MS signal from non-product proteins like HCPs, lower overall deamidation, and no detectable signals from the examined surfactant and polymer foulants under the conditions evaluated. The standardized, plate-based workflow offers a promising approach for biotherapeutic MAM sample preparation. Broader applicability and suitability for use in quality-control require further product-specific qualification or validation. Data are available via ProteomeXchange with identifier PXD086642.

Zitieren

APA

Scherzi, T., Sagatova, A., Wilson, S., & Wilson, J. P. (2026). Standardized Kit-Based Sample Preparation for Multi-Attribute Method Analysis of Biotherapeutics. Pharmaceuticals, 19(11), 1750. https://doi.org/10.3390/ph19111750

Vancouver

Scherzi T, Sagatova A, Wilson S, Wilson JP. Standardized Kit-Based Sample Preparation for Multi-Attribute Method Analysis of Biotherapeutics. Pharmaceuticals. 2026;19(11):1750. doi:10.3390/ph19111750

BibTeX
@article{Scherzi2026,
  author = {Scherzi, Tyler and Sagatova, Alia and Wilson, Sandra and Wilson, John P.},
  title = {Standardized Kit-Based Sample Preparation for Multi-Attribute Method Analysis of Biotherapeutics},
  journal = {Pharmaceuticals},
  year = {2026},
  volume = {19},
  number = {11},
  pages = {1750},
  doi = {10.3390/ph19111750}
}
Kostenlos starten →